Showing results (61-70 of 184) with videos related to
Sort By:
Pageof 19
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 24, 2002
[The effect of high concentration of sodium and potassium ion on motility of human sperm preserved in electrolyte-free solution]Yasushi Yumura, Kazuo Saito, Kotaro Suzuki, et al.Hinyokika Kiyo. Acta Urologica Japonica|April 23, 2004
[Retroperitoneal liposarcoma with reactive pleural effusion: a case report]Makoto Funahashi, Kazuhide Makiyama, Shinpei Sugiura, et al.Journal of Clinical Microbiology|May 1, 2009
Use of reverse transcriptase PCR to subtype N1 to N9 neuraminidase genes of avian influenza virusesKenji Tsukamoto, Takayoshi Ashizawa, Koji Nakanishi, et al.Anticancer Research|October 3, 2018
Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate CancerKotaro Suzuki, Mariko Sakamoto, Tomoaki Terakawa, et al.Molecular and Clinical Oncology|October 18, 2019
Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancerKotaro Suzuki, Tomoaki Terakawa, Katsumi Shigemura, et al.Blood|January 4, 2003
Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activationKei Ikeda, Hiroshi Nakajima, Kotaro Suzuki, et al.Hinyokika Kiyo. Acta Urologica Japonica|August 17, 2006
Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasiaKazumi Noguchi, Kotaro Suzuki, Jun-ichi Teranishi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Involvement of TNF receptor-associated factor 6 in IL-25 receptor signalingYuko Maezawa, Hiroshi Nakajima, Kotaro Suzuki, et al.Plos One|October 4, 2011
Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activationKotaro Suzuki, Samantha H Murphy, Yifeng Xia, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 17, 2004
[Safe retroperitoneoscopic radical nephrectomy with small incision for renal cell carcinoma]Kazuhide Makiyama, Kiyoshi Fujinami, Kotaro Suzuki, et al.Pageof 19